DK396885A - Kemiske forbindelser med beta-blokker-aktivitet, fremgangsmaade til deres fremstilling, kompositioner indeholdende forbindelserne og forbindelsernes anvendelse inden for medicinen - Google Patents

Kemiske forbindelser med beta-blokker-aktivitet, fremgangsmaade til deres fremstilling, kompositioner indeholdende forbindelserne og forbindelsernes anvendelse inden for medicinen Download PDF

Info

Publication number
DK396885A
DK396885A DK396885A DK396885A DK396885A DK 396885 A DK396885 A DK 396885A DK 396885 A DK396885 A DK 396885A DK 396885 A DK396885 A DK 396885A DK 396885 A DK396885 A DK 396885A
Authority
DK
Denmark
Prior art keywords
relations
beta
medicine
procedures
preparation
Prior art date
Application number
DK396885A
Other languages
Danish (da)
English (en)
Other versions
DK396885D0 (da
Inventor
Geoffrey Allan
Donald Bull
George William Hardy
Grahame Roy Lee
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK396885D0 publication Critical patent/DK396885D0/da
Publication of DK396885A publication Critical patent/DK396885A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK396885A 1984-09-01 1985-08-30 Kemiske forbindelser med beta-blokker-aktivitet, fremgangsmaade til deres fremstilling, kompositioner indeholdende forbindelserne og forbindelsernes anvendelse inden for medicinen DK396885A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848422165A GB8422165D0 (en) 1984-09-01 1984-09-01 Compounds

Publications (2)

Publication Number Publication Date
DK396885D0 DK396885D0 (da) 1985-08-30
DK396885A true DK396885A (da) 1986-03-02

Family

ID=10566163

Family Applications (1)

Application Number Title Priority Date Filing Date
DK396885A DK396885A (da) 1984-09-01 1985-08-30 Kemiske forbindelser med beta-blokker-aktivitet, fremgangsmaade til deres fremstilling, kompositioner indeholdende forbindelserne og forbindelsernes anvendelse inden for medicinen

Country Status (16)

Country Link
EP (1) EP0174162A3 (ko)
JP (1) JPS6183198A (ko)
KR (1) KR860002501A (ko)
AU (1) AU581455B2 (ko)
CS (1) CS621585A2 (ko)
DD (1) DD236522A5 (ko)
DK (1) DK396885A (ko)
ES (6) ES8703418A1 (ko)
FI (1) FI853336L (ko)
GB (1) GB8422165D0 (ko)
GR (1) GR852113B (ko)
HU (1) HUT39190A (ko)
MC (1) MC1695A1 (ko)
PL (3) PL265522A1 (ko)
PT (1) PT81055B (ko)
ZA (1) ZA856672B (ko)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0237239A3 (en) * 1986-02-28 1988-08-17 The Wellcome Foundation Limited New compounds
PT84378B (en) * 1986-02-28 1989-01-24 Wellcome Found New compounds
US5346887A (en) * 1987-10-06 1994-09-13 Abbott Laboratories Glaucoma treatment
US5036051A (en) * 1987-10-06 1991-07-30 Abbott Laboratories Glaucoma treatment
US4927807A (en) * 1987-10-06 1990-05-22 Abbott Laboratories Glaucoma treatment
US5187183A (en) * 1988-06-15 1993-02-16 Brigham & Women's Hospital S-nitroso derivatives of ACE inhibitors and the use thereof
US5025001A (en) * 1988-06-15 1991-06-18 Brigham And Women's Hospital S-nitroso derivatives of ACE inhibitors and the use thereof
US5356890A (en) * 1988-06-15 1994-10-18 Brigham And Women's Hospital S-nitroso derivatives of ace inhibitors and the use thereof
US5059589A (en) * 1988-09-08 1991-10-22 Abbott Laboratories Glaucoma treatment
US4916129A (en) * 1989-01-19 1990-04-10 E. I. Du Pont De Nemours And Company Combination β-blocking/angiotensin II blocking antihypertensives
US11229746B2 (en) 2006-06-22 2022-01-25 Excelsior Medical Corporation Antiseptic cap
US9259535B2 (en) 2006-06-22 2016-02-16 Excelsior Medical Corporation Antiseptic cap equipped syringe
US9078992B2 (en) 2008-10-27 2015-07-14 Pursuit Vascular, Inc. Medical device for applying antimicrobial to proximal end of catheter
US9849276B2 (en) 2011-07-12 2017-12-26 Pursuit Vascular, Inc. Method of delivering antimicrobial to a catheter
JP6822978B2 (ja) 2015-05-08 2021-01-27 アイシーユー・メディカル・インコーポレーテッド 治療薬のエミッタを受け入れるように構成された医療用コネクタ
DK3525865T3 (da) 2016-10-14 2022-10-24 Icu Medical Inc Desinficerende hætter til medicinsk konnektorer
WO2018204206A2 (en) 2017-05-01 2018-11-08 Icu Medical, Inc. Medical fluid connectors and methods for providing additives in medical fluid lines
US11541221B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Tubing set with antimicrobial properties
US11534595B2 (en) 2018-11-07 2022-12-27 Icu Medical, Inc. Device for delivering an antimicrobial composition into an infusion device
US11541220B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Needleless connector with antimicrobial properties
US11517732B2 (en) 2018-11-07 2022-12-06 Icu Medical, Inc. Syringe with antimicrobial properties
US11400195B2 (en) 2018-11-07 2022-08-02 Icu Medical, Inc. Peritoneal dialysis transfer set with antimicrobial properties
EP3883638A1 (en) 2018-11-21 2021-09-29 ICU Medical, Inc. Antimicrobial device comprising a cap with ring and insert
WO2022125474A1 (en) 2020-12-07 2022-06-16 Icu Medical, Inc. Peritoneal dialysis caps, systems and methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3705907A (en) * 1970-02-19 1972-12-12 Sandoz Ltd 4-(2-hydroxy)-3-aminopropoxy)-indole derivatives
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
DE3177130D1 (de) * 1980-08-30 1990-01-11 Hoechst Ag Aminosaeurederivate, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung.
GR75019B (ko) * 1980-09-17 1984-07-12 Univ Miami
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4462943A (en) * 1980-11-24 1984-07-31 E. R. Squibb & Sons, Inc. Carboxyalkyl amino acid derivatives of various substituted prolines
EP0080822A1 (en) * 1981-11-27 1983-06-08 Beecham Group Plc Anti-hypertensive prolinol-based peptides
CA1341296C (en) * 1981-12-29 2001-09-25 Hansjorg Urbach 2-azabicycloalkane-3-carboxylic acid derivatives, processes for their preparation, agents containing these compounds and their use
DE3360065D1 (en) * 1982-03-08 1985-03-28 Schering Corp Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
AU560285B2 (en) * 1982-07-19 1987-04-02 Imperial Chemical Industries Plc Heterocyclyl carbonyl sulphonamides

Also Published As

Publication number Publication date
GR852113B (ko) 1985-12-24
EP0174162A3 (en) 1988-07-27
AU4693285A (en) 1986-03-06
PT81055B (en) 1987-07-02
ZA856672B (en) 1987-05-27
JPS6183198A (ja) 1986-04-26
PL265522A1 (en) 1988-05-12
EP0174162A2 (en) 1986-03-12
PL265523A1 (en) 1988-02-04
ES553613A0 (es) 1988-01-01
CS621585A2 (en) 1989-08-14
FI853336A0 (fi) 1985-08-30
ES553610A0 (es) 1988-01-01
DK396885D0 (da) 1985-08-30
ES8801312A1 (es) 1987-12-16
PL255192A1 (en) 1987-09-21
ES553611A0 (es) 1987-12-16
MC1695A1 (fr) 1986-07-18
ES8703418A1 (es) 1987-02-16
AU581455B2 (en) 1989-02-23
GB8422165D0 (en) 1984-10-03
ES8801313A1 (es) 1988-01-01
HUT39190A (en) 1986-08-28
ES553614A0 (es) 1988-02-16
ES8801310A1 (es) 1988-01-01
ES8801311A1 (es) 1987-12-16
ES8801672A1 (es) 1988-02-16
ES546595A0 (es) 1987-02-16
KR860002501A (ko) 1986-04-26
FI853336L (fi) 1986-03-02
DD236522A5 (de) 1986-06-11
ES553612A0 (es) 1987-12-16
PT81055A (en) 1985-09-01

Similar Documents

Publication Publication Date Title
DK396885A (da) Kemiske forbindelser med beta-blokker-aktivitet, fremgangsmaade til deres fremstilling, kompositioner indeholdende forbindelserne og forbindelsernes anvendelse inden for medicinen
DK87886A (da) Thiazolidinderivater, deres fremstilling og anvendelse
DK273689D0 (da) 4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler
NO862095L (no) Farmasoeytiske preparater inneholdende vevsplasmnogenaktivitator og fremgangsmaate for deres fremstilling.
DK129386A (da) Iodpropargylethere, deres fremstilling og anvendelse
DK493386A (da) Benzimidazoler, -oxazoler og -thiazoler, deres anvendelse i farmaceutiske kompositioner og fremgangsmaade til forbindelsernes fremstilling
DK158522C (da) Beta-amylase, samt fremstilling og anvendelse deraf
DK519586A (da) 1-aryl-4-nitro-pyrazoler, deres fremstilling og anvendelse
DK409886A (da) Azolyl-cyclopropyl-ethanol-derivater, fremgangsmaade til deres fremstilling og deres anvendelse
DK90582A (da) 1-benzoyl-3-arylpyridyl-urinstoffer eller syreadditionssalte deraf deres fremstilling og anvendelse til insektbekaempelse
DK385185D0 (da) Substituerede phenylurinstoffer, deres fremstilling og anvendelse
DK470286D0 (da) Cementholdige tilslagsstoffer og deres anvendelse
DK133587A (da) 2-heterocyclylthio-penemer, deres anvendelse og farmaceutisk komposition indeholdende forbindelserne
DK76587D0 (da) Thioforbindelser med fungicid aktivitet, fremgangsmaade til deres fremstilling og deres anvendelse
DK399985D0 (da) 6-substituerede mitomycin-analoge, deres anvendelse inden for medicinen og kompositioner indeholdende forbindelserne
DK420986D0 (da) Dihydropyridin-2-hydroxyaminer, fremgangsmaade til deres fremstilling og deres anvendelse i laege-midler
DK380286A (da) Sulfonamider, deres fremstilling og anvendelse
DK617886D0 (da) 1-aryl-pyrazoler, deres fremstilling og anvendelse
DK396886D0 (da) Gem-dihalogen-1,8-diamino-4-azaoctaner, deres fremstilling og anvendelse
DK402585A (da) Pseudooligosaccharider med alfa-glucosidase-inhiberende virkning, deres fremstilling og anvendelse samt farmaceutiske praeparater
DK377786A (da) 1-aryl-5-hydrazino-pyrazoler, deres fremstilling og anvendelse
DK292685A (da) Thiazolidinderivater og fremgangsmaader til fremstilling deraf
DK564986D0 (da) Thienylurinstofderivater, deres fremstilling og anvendelse
DK478586A (da) Polyhydroxyalkyl-oligourinstoffer og deres anvendelse
DK393986D0 (da) Lactamamider, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment